Our experience with MRI – ultrasound fusion prostate biopsy at Uzsoki Street Hospital
DOI: 10.22591/magyurol.2025.1.horvathl.15
Authors:
Horváth László dr.1, Tóth Zoltán dr.1, Zolcsák Attila dr.1, Kátai Tamás Zoltán dr.2
1Uzsoki Utcai Kórház, Urológiai Sebészeti Osztály, Budapest (osztályvezető: Tóth Zoltán dr.)
2Uzsoki Utcai Kórház, Központi Röntgen Diagnosztika, Budapest (osztályvezető: Egyed Zsófia dr.)
Summary
Introduction: Prostate cancer (PCa) is the second most common cancer among men. After the routine PSA blood sampling and rectal digital examination the histological sampling is the standard method of the final diagnosis.
Usually, the conventional map biopsy is used, but nowadays it is possible to perform a transrectal ultrasound guided MRI fusion biopsy of suspicious lesions.
Patients and methods: At the Urology Department of the Uzsoki Street Hospital, 77 ultrasound guided MRI fusion biopsy cases were performed between May 2020 and March 2023. Patients with suspected prostate cancer were selected randomly based on the regional duty of care.
Results: From the 55 biopsy naive patients, 42 were confirmed to have prostate cancer, 28 (51%) with clinically significant grade >ISUP1. From the 22 patients who underwent previous biopsy, 14 were confirmed to have PCa, 8 (36%) >ISUP1.
In 14% of all patients, 19.5% of all positive results, prostate cancer was detected only by MR fusion biopsy, 6 cases >ISUP1 grade.
Conclusion: Transrectal ultrasound guided MRI fusion biopsy is considered an indispensable diagnostic modality in the routine urological practice, and can be performed with the same time as the convection biopsy in an outpatient setting with a similar complication rate. There were no significant differences between radiology departments.